This text is a result of machine translation.
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
NK Celltech Receives a Series A Round of Funding Worth More Than CNY 100 Million
NK Celltech recently received a Series A round of funding totaling more than CNY 100 million. Huagai Capital led this round of funding, which was followed by CASVC, Unifortune, 呈益资本, Sirius Capital, and QJ Capital.
Jul 01, 2022 03:58 PM
Exclusive Interview with Ray Hu, Founder and Managing Partner of Blue Lake Capital
Updated 9 hours ago
An Overview of China’s Robotaxi Industry in 2022 for Overseas Investors
Updated 14 hours ago